Hester Biosciences Limited (NSE:HESTERBIO)

Hester Biosciences Revenue

In the fiscal year ending March 31, 2026, Hester Biosciences had annual revenue of 3.42B INR with 9.54% growth. Hester Biosciences had revenue of 970.82M in the quarter ending March 31, 2026, with 34.05% growth.

• Revenue: 3.42B
• Revenue Growth: +9.54%
• P/S Ratio: 4.78
• Revenue / Employee: 5.92M
• Employees: 562
• Market Cap: 15.89B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	3.42B	298.09M	9.54%
Mar 31, 2025	3.12B	12.80M	0.41%
Mar 31, 2024	3.11B	329.89M	11.86%
Mar 31, 2023	2.78B	315.58M	12.79%
Mar 31, 2022	2.47B	289.51M	13.30%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 21, 2026

Data Sources Report a data error